Durham, NC, United States of America

Justyna E Wolak-Dinsmore

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Justyna E Wolak-Dinsmore: Innovator in Diabetes Risk Evaluation and NMR Quantification

Introduction

Justyna E Wolak-Dinsmore is a prominent inventor based in Durham, NC (US). She has made significant contributions to the fields of diabetes risk evaluation and nuclear magnetic resonance (NMR) quantification. With a total of 11 patents to her name, her work has the potential to impact healthcare and diagnostics.

Latest Patents

One of her latest patents focuses on the NMR quantification of trimethylamine-N-oxide (TMAO). This invention involves electronically evaluating a defined peak region in a proton NMR spectrum of an in vitro biosample to determine TMAO levels. The biosamples can include human serum and urine, with specified normal biologic ranges. Another notable patent is related to multi-parameter diabetes risk evaluations. This invention includes methods, systems, and circuits that assess a subject's risk of developing type 2 diabetes or prediabetes using defined mathematical models. These models can stratify risk for patients with similar glucose measurements, incorporating NMR-derived measurements of GlycA and various lipoprotein components.

Career Highlights

Throughout her career, Justyna has worked with notable companies, including Liposcience, Inc. Her innovative approaches have positioned her as a leader in her field, contributing to advancements in medical diagnostics and risk assessment.

Collaborations

Justyna has collaborated with esteemed colleagues such as James D Otvos and Dennis W Bennett. These partnerships have further enhanced her research and development efforts.

Conclusion

Justyna E Wolak-Dinsmore is a trailblazer in the realm of medical innovation, particularly in diabetes risk evaluation and NMR quantification. Her contributions through her patents and collaborations continue to shape the future of healthcare diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…